Cargando…
Identification of new small molecules as dual FoxM1 and Hsp70 inhibitors using computational methods
BACKGROUND AND PURPOSE: FoxM1 and Hsp70 proteins are highly expressed in many cancers. Thus, their inhibition serves as Bonafede targets in cancer treatment. EXPERIMENTAL APPROACH: FDI-6, an inhibitor of FoxM1, was selected as a template, and based on its structure, a new library from the ZINC datab...
Autores principales: | Alimardan, Zahra, Abbasi, Maryam, Khodarahmi, Ghadamali, Kashfi, Khosrow, Hasanzadeh, Farshid, Mahmud, Aghaei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9872178/ https://www.ncbi.nlm.nih.gov/pubmed/36704430 http://dx.doi.org/10.4103/1735-5362.359431 |
Ejemplares similares
-
Benzofuran as a promising scaffold for the synthesis of antimicrobial and antibreast cancer agents: A review
por: Khodarahmi, Ghadamali, et al.
Publicado: (2015) -
FoxM1 is Upregulated in Osteosarcoma and Inhibition of FoxM1 Decreases Osteosarcoma Cell Proliferation, Migration, and Invasion
por: Zhu, Xia, et al.
Publicado: (2020) -
Synthesis and cytotoxic evaluation of some novel quinoxalinedione diarylamide sorafenib analogues
por: Khandan, Mojtaba, et al.
Publicado: (2018) -
Quantum mechanical/molecular mechanical and docking study of the novel analogues based on hybridization of common pharmacophores as potential anti-breast cancer agents
por: Asadi, Parvin, et al.
Publicado: (2017) -
Synthesis, cytotoxic evaluation, and molecular docking studies of some new 1, 3, 4-oxadiazole-based compounds
por: Hassanzadeh, Farshid, et al.
Publicado: (2020)